Aminopyrimidines useful as kinase inhibitors

Details for Australian Patent Application No. 2008247595 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Mortimore, Michael; Robinson, Daniel; Golec, Julian

Agent Baldwins

Pub. Number AU-A-2008247595

PCT Pub. Number WO2008/137622

Priority 60/915,579 02.05.07 US

Filing date 2 May 2008

Wipo publication date 13 November 2008

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/137622 Priority application(s): WO2008/137622

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247603-Use of HDAC inhibitors for the treatment of gastrointestinal cancers

2008247594-Aminopyrimidines useful as kinase inhibitors